SL
GILD icon

Savior LLC’s Gilead Sciences GILD Stock Holding History

Savior LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 170
2021
Q4 		$0 Buy
+1
New +$69 ﹤0.01% 189
2021
Q3 		– Sell
-94
Closed -$6.6K – 418
2021
Q2 		$6K Hold
94
– – 0.01% 518
2021
Q1 		$6K Hold
94
– – 0.01% 533
2020
Q4 		$5K Sell
94
-7
-7% -$422 ﹤0.01% 553
2020
Q3 		$6K Hold
101
– – 0.01% 475
2020
Q2 		$8K Sell
101
-144
-59% -$11K 0.01% 370
2020
Q1 		$18K Sell
245
-96
-28% -$6.63K 0.02% 225
2019
Q4 		$22K Buy
+341
New +$22.2K 0.03% 283

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Savior LLC's GILD Position: Q1 2022 in Review

Savior LLC sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 1 share.

Savior LLC first reported a position in GILD in Q4 2019 and held it in 8 quarters. The position peaked at $22K in Q4 2019. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Savior LLC reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Savior LLC sold 1 Gilead Sciences share in Q1 2022.
  • Savior LLC first reported a position in Gilead Sciences in Q4 2019 and held it in 8 quarters.
  • Savior LLC's Gilead Sciences position peaked at $22K in Q4 2019.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Savior LLC's 13F filing for Q1 2022, filed 12 Apr 2022.